FIG. 1.

Flowchart of current and potential future options for management of patients receiving basal–bolus therapy. The first clinical decision is whether to add CGM, to add CSII, or introduce both CGM and CSII. CGM, continuous glucose monitoring; CSII, continuous subcutaneous insulin infusion.